Repository logo
 

Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data from Individual Patients

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Type

Article

Change log

Authors

Fitzgerald, RC 

Abstract

BACKGROUND AND AIMS Diagnosis and surveillance of Barrett’s esophagus (BE) and eosinophilic esophagitis (EoE) have become emerging public health issues. Cytosponge® is a novel, minimally invasive esophageal cell collection device. We aimed to assess the data on safety and acceptability of this device. METHODS We performed a patient-level review of 5 prospective trials assessing Cytosponge® performance in patients with reflux disease, BE and EoE in primary and secondary care. Acceptability of Cytosponge® and subsequent endoscopy were recorded with visual analogue scale (VAS), wherein 0 and 10 denoted lowest and highest acceptability. Median VAS scores were compared using a Mann-Whitney test. The number of attempts, failures in swallowing the device and occurrence of adverse events were analyzed. Risk factors for failure in swallowing were analyzed using a multivariate regression model. RESULTS In total 2,672 Cytosponge® procedures were performed in 2,418 individuals between 2008 and 2017. There were two adverse events related to the device: a minor pharyngeal bleed and one case of detachment (<1:2,000). The median acceptability score for the Cytosponge® was 6.0 (IQR 5.0-8.0), which was higher than endoscopywithout sedation (median 5.0, IQR 3.0-7.0; p<0.001) and lower than endoscopy with sedation (median 8.0, IQR 5.0-9.0; p<0.001). Nearly all patients (91.1%) successfully swallowed the Cytosponge® and most (90.1%) were achieved with the first swallow attempt. Failure to swallow the device was more likely to occur in secondary care (OR= 5.13, 95%CI 1.48-17.79, P<0.01). CONCLUSIONS The Cytosponge® test is a safe procedure with good acceptability ratings in a variety of health care settings.

Description

Keywords

Journal Title

Clinical Gastroenterology and Hepatology

Conference Name

Journal ISSN

1542-3565

Volume Title

17

Publisher

Elsevier
Sponsorship
Cancer Research UK (C14478/A12088)
Cancer Research Uk (None)